IBB Archives - Spark Newswire

2 minute read

Activist Investor Elliott Pushes for Strategy Revamp at BioMarin Amid CEO Change

November 7, 5:12 PM

Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc (NASDAQ: BMRN), engaging with the company on its strategic direction amid leadership changes and the evolving status of its

BMRN

1 minute read

Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed

By Piero Cingari

August 31, 12:48 PM

The major U.S. stock indices, closely monitored through ETFs — the SPDR S&P 500 ETF Trust (NYSE:IWM) —…

DIA

2 minute read

Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk’s stock, Pushing Valuation Past Denmark’s GDP

By Shanthi Rexaline

August 12, 3:31 PM

Shares of weight-loss drug manufacturers came to the party last week on the back of positive news flow…

IBB

2 minute read

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss

By Piero Cingari

August 10, 11:58 AM

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from…

APP

1 minute read

Rising Stars, Falling Trends: July’s Industry ETF Winners and Losers

By Piero Cingari

July 31, 10:59 AM

As July comes to an end, it’s time to take a look at the best- and worst-performing industry…

AAL

2 minute read

Women’s Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules

By Vandana Singh

April 13, 7:38 AM

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug.

BBH

1 minute read

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications

By Vandana Singh

April 12, 9:46 AM

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this week.

BBH

1 minute read

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: “Devastating Risks” Ahead

By Vandana Singh

April 11, 2:28 PM

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating risks to millions of people," including those in states where abortion remains legal.

BBH

1 minute read

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits

By Vandana Singh

April 6, 1:45 PM

Today, the FDA announced the final decision to withdraw approval of Privately held-Covis Pharma’s Makena (hydroxyprogesterone caproate injection), a drug approved…

BBH

1 minute read

AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC’s ‘Final Trades’

By Priya Nigam

April 6, 8:49 AM

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she is sticking with AbbVie Inc. (NYSE: ABBV), which has a 7.3% free cash flow yiel

ABBV

Feed Symbols: IBB